{"nct_id":"NCT00715624","title":"GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin","status":"COMPLETED","status_verified_date":"2016-10","start_date":"2008-07","start_date_type":null,"primary_completion_date":"2011-02","primary_completion_date_type":"ACTUAL","completion_date":"2011-02","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["SNY"]}